Afrezza, invented by MannKind, a Connecticut-based pharmaceutical company, is the only inhalable insulin in existence. It’s actually been on the market once before. When it was first launched, about a decade ago, the apparatus to take the insulin was so giant and ill conceived that some likened it to a bong. The new inhaler is small enough to fit inside a jean pocket or my curled palm.

Read more